Bausch Health Companies (BHC) PT Raised to $35 at Mizuho Securities on Improved Margins

August 22, 2018 6:31 AM EDT
Get Alerts BHC Hot Sheet
Price: $7.03 +3.08%

Rating Summary:
    15 Buy, 11 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 6 | Down: 15 | New: 16
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Mizuho Securities analyst Irina Koffler raised the price target on Bausch Health Companies (NYSE: BHC) to $35.00 (from $31.00) while maintaining a Buy rating.

Koffler cited continued margin improvement that may drive 3.2% incremental improvements in EBITDA by 2022.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change

Related Entities

Irina Koffler